home / stock / mycof / mycof news

MYCOF News and Press, New Age Brands From 04/25/24

Stock Information
Company Name: New Age Brands
Stock Symbol: MYCOF
Market: OTC
Website: mydecine.com
Menu
MYCOF MYCOF Quote MYCOF Short MYCOF News MYCOF Articles MYCOF Message Board
Get MYCOF Alerts

News, Short Squeeze, Breakout and More Instantly...
MYCOF - Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order

(TheNewswire) VANCOUVER, British Columbia – TheNewswire - April 25, 2024 — Mydecine Innovations Group Inc. (the “ Company ”) (CSE:MYCO) (FSE:0NF0) (OTC:MYCOF) (AQSE:MYIG) announces that as a result of a review by the British Columbia...
MYCOF - Mydecine Innovations Group Inc. Announces Closing Of Share For Debt Settlement

(TheNewswire) VANCOUVER, BC – TheNewswire - (15 April 2024 ) Mydecine Innovations Group Inc . (CSE: MYCO) (AQSE: MYIG) (FSE: 0NFA) (OTC: MYCOF) (the “ Company ” or “ Mydecine ”) announces that it has closed two d...

MYCOF - Mydecine Innovations Group Inc. Announces Closing of Share for Debt Settlement

(TheNewswire) V ANCOUVER, BC – ( TheNewswire / 27 March 2024 ) Mydecine Innovations Group Inc . (CSE: MYCO) (AQSE: MYIG) (FSE: 0NFA) (OTC: MYCOF) (the “ Company ” or “ Mydecine ”) announces that it has closed...

MYCOF - Mydecine: Nature's Medicine for Mental Health

2024-03-27 17:08:02 ET Treating mental health problems and enhancing vitality Mydecine Innovations is dedicated to developing and commercializing innovative solutions for treating mental health problems and enhancing vitality. Its world-renowned medical and scientific adv...
MYCOF - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement

Mydecine Innovations (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) (FSE: 0NF0) , a leading biotechnology company dedicated to transforming mental-health and addiction treatment, has entered into a debt settlement agreement. The agreement is designed to partially settle outstanding debts owed for legal se...

MYCOF - Mydecine Innovations Group Inc. Announces Share for Debt Settlement

--News Direct-- VANCOUVER, BC / TheNewswire / 20 March 2024 -- Mydecine Innovations Group Inc. (CSE: MYCO) (FSE: 0NFA), (OTC: MYCOF) (AQSE: MYIG) (the “Company” or “Mydecine”) announced that it has entered into a debt settlement agreement (the “Settlement Ag...

MYCOF - Psychedelic stocks gain after FDA priority review for MDMA therapy

2024-02-12 12:13:32 ET More on ATAI, COMPASS Pathways, etc. Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts De-Risking Psychedelics: Compass Pathways, Cybin And Atai ...
MYCOF - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Compounds Receive USPTO Notice of Allowances

Mydecine Innovations (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) (FSE: 0NF0) , a leading biotechnology company dedicated to transforming mental-health and addiction treatment, has been issued two Notice of Allowances by the United States Patent and Trademark Office (“USPTO”). The allowanc...

MYCOF - Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds

VANCOUVER, British Columbia, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NF0), a leading biotechnology company dedicated to transforming mental health and addiction treatment, ...

MYCOF - Mydecine Innovations Group Announces Director Resignation

VANCOUVER, British Columbia, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE: 0NF0), a forefront biotechnology company dedicated to revolutionizing mental health and addiction treat...
Previous 10 Next 10